Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low ba...

Yazar: Hale, Martin E, Nalamachu, Srinivas R, Khan, Arif, Kutch, Michael
Baskı/Yayın Bilgisi 2013

Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with...

Yazar: Hale, Martin E, Laudadio, Charles, Yang, Ronghua, Narayana, Arvind, Malamut, Richard
Yayımlandı J Pain Res (2015)

A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving O...

Yazar: Webster, Lynn R, Hale, Martin E, Yamada, Tadaaki, Wild, James E
Yayımlandı J Pain Res (2020)

A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain

Yazar: Nalamachu, Srinivas, Rauck, Richard L, Hale, Martin E, Florete, Orlando G, Robinson, Cynthia Y, Farr, Stephen J
Yayımlandı J Pain Res (2014)

Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives

Yazar: Hale, Martin E., Wild, James E., Yamada, Tadaaki, Yokota, Takaaki, Tack, Jan, Andresen, Viola, Drewes, Asbjørn Mohr
Yayımlandı Therap Adv Gastroenterol (2021)